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Niravkumar K. Sangani, MD, and Rakesh M. Suri, MD, DPhilRapid advances in expandable stent technology to treatcardiac diseases have led to the development of
sutureless aortic valve devices. They provide an innovative
treatment option for less-invasive and more rapid aortic
valve replacement. To date, the devices have generally
been used in elderly and high–surgical risk patients with
severe calciﬁc aortic stenosis with the goal of decreasing
the morbidity and mortality in them by shortening
cardiopulmonary and cardiac ischemic times, therebye front matter r 2013 Elsevier Inc. All rights reserved.
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i.rakesh@mayo.eduimproving surgical outcomes. These so-called quick-
deploy sutureless valves are now being used in lower-
risk patients when both a bioprosthetic device and a
minimally invasive approach are preferred by the patient.
We describe the technical implantation of 3 suture-
less aortic valves that have been used clinically either in
Europe or in North America: the Perceval S (Sorin, Italy),
3f Enable (Medtronic, USA), and INTUITY (Edwards, USA)
(Figs. 1-15).
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Figure 1 Perceval S valve. The Perceval S valve consists of 3 bovine pericardial cusps mounted on a self-expanding nitinol stent. It has an
inﬂow skirt anchoring the valve within the aortic annulus and an outﬂow ring stabilizing the valve at the sinotubular junction. The nitinol
stent exerts an outward radial force, facilitating ﬁxation of the device. It has 2 sets of struts—(1) “sinusoidal,” which conform to the sinuses of
Valsalva and (2) “straight commissural” to support the valve. It has 3 eyelets on the inﬂow ring for passage of guide sutures. This valve is
collapsed without compressing the pericardial leaﬂets and positioned in a valve delivery system. The Perceval S valve is available in 3 sizes in
North America currently: small (S), medium (M), and large (L). The corresponding aortic annulus diameters are S (19-21 mm), M (21-
23 mm), and L (23-25 mm). The prosthesis heights are S (31.0 mm), M (33.0 mm), and L (35.5 mm). Eligible patients are adults with either
severe aortic valve stenosis or aortic valve stenosis with regurgitation. The valve is not recommended in the following scenarios: (1) congenital
bicuspid valve replacement with asymmetric sinuses of Valsalva, (2) aortic annulus diametero19 mm or425 mm, or (3) a ratio between the
sinotubular junction and the annulus diameter41.3 as determined by echocardiography as it can prevent correct ﬁxation of the valve stent
within the sinus portion of the aorta.1 The concomitant procedures performed can include coronary bypass grafting, left atrial appendage
ligation, and septal myectomy, according to the FDA investigational device exemption protocol.
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Figure 2 High aortotomy. After induction under general anesthesia and placement of monitoring lines, transesophageal echocardiography is
performed to assess cardiac anatomy and function. The surgical approach can be via median sternotomy, upper ministernotomy, or right
minithoracotomy. The patient is placed on cardiopulmonary bypass. After cross-clamping and arresting the heart, the aortotomy is
performed. The aortotomy should be transverse and slightly higher than for a conventional valve because of the height of the stent; at least
0.5 cm above the sinotubular junction or 3.5 cm measured outside the aorta from the aortic annulus. The level of the “Concato” preaortic fat
pad can be taken as the reference point for the aortotomy. An oblique aortotomy is not recommended as it could result in difﬁculty with
aortotomy closure. Three pledgeted stay sutures are inserted on the superior (1) and inferior (2) margin of the aortotomy for better exposure.
The leaﬂets are excised and the annulus is debrided to create a smooth circular oriﬁce. Complete decalciﬁcation is not necessary but bulky and
eccentric intraluminal calciﬁcations must be removed.
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Figure 3 Valve sizing. The annulus is sized with a commercially provided proprietary valve sizer that has both a transparent obturator
identiﬁed with a tick (✓) symbol and a white obturator demarcated with a cross symbol (). The intra-annular (transparent) head of one has
the same external diameter as the supra-annular (white) head of the one with a smaller size. It is recommended that the surgeon begin from
the smallest size available (S). When the transparent obturator passes through the annulus and the white obturator does not, the valve size
identiﬁed on that speciﬁc sizer handle is chosen. If the transparent obturator of size S cannot pass through the annulus, the small (S) Perceval
S valve cannot be implanted. The prosthesis should not be undersized or oversized as it could cause excessive compression or rupture of the
aorta, migration, stent folding, fatal arrhythmia, regurgitation, hemorrhage, or altered hemodynamics.
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Figure 4 Collapsing of valve. A dual collapser appropriate for the size of the selected prosthesis is used. The valve holder is ﬁxed on the base by
aligning the groove on the handle with the notch on the support. The valve is inserted in the collapsing tool until the sinusoidal struts of the
valve ﬁt ﬁrmly between the reference markers of the collapsing tool. By gently turning the lever of the dual collapser, the inﬂow and outﬂow
rings are collapsed. The cusps are not crimped and are freely mobile. The collapsed prosthesis is kept in a warm sterile solution.
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Figure 5 Placement of guiding sutures. Three double-needle prolene sutures are passed through the aortic annulus at the midpoint between 2
commissures. They must be placed equidistantly around the aortic annulus, with 1201 between sutures. Once the suture has been placed, it is
recommended that the needle on the aortic side of the annulus be removed immediately to prevent confusion. Each suture is passed through
one of the eyelets of the prosthesis inﬂow ring. Care is taken to pass the needle that has exited the inferior portion of the annulus through the
suture guide. The 3 sutures are then merely used to guide the prosthesis into the aortic annulus and ensure correct positioning of the valve
with respect to rotational and axial axes.
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Figure 6 Lowering of valve. Keeping the guide sutures taut with a gentle pull, the holder loaded with the valve is parachuted down into the
aortic annulus until it stops at the insertion point of the ventricular aspect of the sutures themselves. The inﬂow section is released ﬁrst by
rotating the knob clockwise at the end of the holder. The outﬂow section is then released by removing the safety clip and then withdrawing
the sliding sheath of the holder superiorly. Several visual assessments are made at this point: (1) the parallel orientation of the sinusoidal and
commissural struts, (2) the absence of annulus protrusion above a uniformly deployed inﬂow skirt, (3) creation of a symmetrical “Mercedes-
Benz” sign by symmetric apposition of all 3 pericardial cusps, and (4) full mobility of the anterior mitral leaﬂet.
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Figure 7 Balloon inﬂation. Once the aforementioned checks have been performed, the prosthesis inﬂow skirt is dilated with a balloon-tipped
catheter to optimize the area of contact with the aortic annulus. The size of the chosen balloon corresponds to that of the implanted valve. The
deﬂated balloon is inserted across the valve just to the point where the blue disc at the superior margin reaches the leaﬂet tips. The balloon is
inﬂated at 4 atm for 30 seconds and the aortic root is bathed with a continuous stream of warm saline at 371C. The balloon is then deﬂated
and carefully removed. Complete contact between the inﬂow ring and the annulus with appropriate sinus strut position is veriﬁed. Coronary
ostia patency, absence of perivalvular spaces, and leaﬂet coaptation are conﬁrmed. The guiding sutures are removed. The aortotomy is then
closed, taking care that the suture does not become entrapped within the struts. The left heart is deaired and the cross-clamp is removed, after
which the patient is weaned off cardiopulmonary bypass. Intraoperative transesophageal echocardiography is performed to conﬁrm normal
cardiac function and prosthetic valve hemodynamics, normal coronary ﬂow, and the absence of valvular or perivalvular regurgitation. The
seating of the inﬂow and outﬂow rings, systolic excursion, and coaptation of the cusps are veriﬁed. On the ﬁrst postoperative day, aspirin is
given for postoperative anticoagulation. A transthoracic echocardiography is performed at the time of discharge and at regularly scheduled
visits following surgery.
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Figure 8 3f Enable valve. The 3f Enable aortic bioprosthesis consists of the 3f aortic valve made of equine pericardium mounted on a self-
expanding nitinol frame and covered with polyester on the inﬂow aspect. Three commissural tabs are present at the superior aspect of the
nitinol frame. A folding sleeve is attached to the valve. The valve is available in sizes 19-29 mm. The properties of nitinol and the ﬂexibility of
equine pericardial leaﬂets allow the device to be folded at low temperatures. The device returns to its original dimensions upon deployment at
room temperature.2 The exclusion criteria include active endocarditis and dilated ascending aorta or aortic root. Discordance between the
sinotubular ridge and diameter of the aortic annulus is not of concern for this type of valve because ﬁxation occurs only at the level of the
annulus.3
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Figure 9 Valve folding. A transverse aortotomy is performed 2 cm above the sinotubular junction, the native valve is excised, and the annulus
is debrided. The annulus is measured using specially designed sizers. The valve is rinsed in saline solution, immersed in ice bath (at 41C), and
folded.
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Figure 10 Insertion in deployment tool. A “ring” is used to keep it in the collapsed position. The suture connecting the folding sleeve and valve
is cut. The folded valve is inserted within the proprietary deployment tool.
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Figure 11 Guiding suture placement. A single suture is placed at the nadir of the non-coronary sinus. The guiding suture is then passed
through the suture ring of the valve after aligning the tabs of the prosthesis with the native valve commissures.
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Figure 12 Expanded valve. The valve is inserted and expanded with a continuous inﬂux of warm saline solution (371C). The tabs come into
contact with the aortic wall after expansion of the valve. The valve is inspected and, if necessary, repositioned by rinsing it with chilled saline.
The guiding suture is tied, and the aortotomy is closed.
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Figure 13 INTUITY valve. The INTUITY valve is a trileaﬂet bovine pericardial device. It has a balloon-expandable stainless steel frame under
the valve at the inﬂow aspect, covered by a polyester sealing cloth. The valve is available in sizes 19-27 mm. The exclusion criteria for use
include active infective endocarditis and ascending aortic dilatation.
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Figure 14 Guiding sutures placement. The aortotomy can be “standard,” “hockey stick,” or “lazy S.” After excision of the valve and
decalciﬁcation, the annulus is sized. Three equidistantly spaced guiding sutures are placed at the nadir of each aortic sinus in a “ﬁgure-of-8”
conﬁguration. The valve is washed in saline solution. Both the needles of each of the 3 sutures are passed through the corresponding portions
of the valve-sewing ring at the black markers.
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Figure 15 Balloon inﬂation. By using the guiding sutures, the valve and its delivery system are parachuted down the aortic annulus. The
sutures are snared with a tourniquet. The balloon catheter is inserted through the holding device. The balloon is inﬂated with saline for 10
seconds. The recommended inﬂation pressures are 3 atm for 19 and 21 mm, 4 atm for 23 and 25 mm, and 5 atm for 27 mm. Balloon
inﬂation expands the stent frame in the left ventricular outﬂow tract.4 The entire holding device and balloon are then removed as a single unit.
The 3 guiding sutures are tied and the aortotomy is closed.
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Recent evidence suggests that current-generation sutureless
aortic valves can be deployed and implanted rapidly and
have the potential of reducing cross-clamp and total bypass
times.5,6 European reports indicate that they can be used
safely with favorable early clinical and hemodynamic
outcomes.3-6 As with any new technique, deployment is to
be associated with a necessary learning curve; however,
advances in sutureless valve design and deployment
techniques have facilitated the use of these new devices in
minimally invasive and small-incision cardiac surgical
approaches. The ability to dispense with tied suture knots,
the availability of excellent visualization during positioning,
rapid device expansion, and diminished requirement for
manipulation of the aortic root wall during insertion
represent signiﬁcant advances with potential patient beneﬁt.
In patients with a small aortic annulus, the absence of a
bulky sewing cuff may further allow maximization and
optimization of bioprosthetic oriﬁce diameter available for
left ventricular outﬂow. These devices may thus potentially
add surgical value across a broad spectrum, from a high-risk
patient with compromised left ventricular function to low
intermediate risk patients searching for a less-invasive
method to allow full excision of native calciﬁc aortic diseases
and true “replacement” with a new bioprosthetic device.6,7
Long-term studies will be necessary to understand durabilityand hemodynamic performance compared with the gold
standard conventional aortic valve replacement and nascent
transcatheter technology.References
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